Antiplatelet Therapy in Cardiovascular Disease (eBook)
John Wiley & Sons (Verlag)
978-1-118-49402-8 (ISBN)
This important new book:
- Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how these therapies work and why they can also produce such a varied range of complications, from minor gastrointestinal upset, to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells.
- Thoroughly covers platelet function testing, including new, novel techniques.
- Clarifies current best-practices regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease
- Reviews of all types of antiplatelet agents – from aspirin to recently approved drugs – including indications, clinical outcomes, and side effects/complications
Written by an international who's-who of experts in the field, Antiplatelet Therapy also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to Interventional Cardiologists.
Edited by a team of the world s leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-to-drug interactions, and resistance to antiplatelet agents. This important new book: Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells. Thoroughly covers platelet function testing, including novel techniques. Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease. Reviews all types of antiplatelet agents from aspirin to recently approved drugs including indications, clinical outcomes, and side effects. Written by an international who s who of experts in the field, Antiplatelet Therapy in Cardiovascular Disease also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to interventional cardiologists.
Ron Waksman, MD, FACC, is Associate Director, Division of Cardiology and Director of Experimental Angioplasty & New Technologies, Washington Hospital Center, Washington, DC. Dr. Waksman is currently the Editor-in-Chief of Cardiovascular Revascularization Medicine and sits on the editorial boards of six other internationally published journals. He has been Editor/Co-Editor of six books since 1996 and has authored 22 additional book chapters. Dr. Waksman has also authored/co-authored over 250 published manuscripts and over 200 abstracts. He is also a Clinical Professor of Medicine (Cardiology) at Georgetown University, Washington, DC, USA.
"Written by an international who's-who of experts
in the field, Antiplatelet Therapy also includes an entire section
covering the use of antiplatelet drugs in PCIs, including
percutaneous valve repair, which makes this text particularly
essential to Interventional Cardiologists."
(Kingbook73's Medical Ebook and Video Collection, 20 August
2014)
List of Contributors
Yousif Ahmad, BMedSci, BMBS, MRCP
Cardiology SpR and Honorary Research Fellow
National Heart and Lung Institute
Imperial College London
London;
University of Birmingham Centre for Cardiovascular Sciences
City Hospital
Birmingham, UK
Dominick J. Angiolillo, MD, PhD
Associate Professor of Medicine
Director, Cardiovascular Research
University of Florida College of Medicine
Jacksonville, FL, USA
Nachiket Apte, MBBS
Resident
Sinai Center for Thrombosis Research
Sinai Hospital of Baltimore;
Johns Hopkins University School of Medicine
Baltimore, MD, USA
Deborah E. Aronson, PhD
Medical Publication Editor
The Zena and Michael A. Wiener Cardiovascular Institute
The Icahn School of Medicine at Mount Sinai
New York, NY, USA
Nevin C. Baker, DO
Fellow, Interventional Cardiology
MedStar Washington Hospital Center
Washington, DC, USA
Sameer Bansilal, MD, MS
Assistant Professor
The Zena and Michael A. Wiener Cardiovascular Institute
The Icahn School of Medicine at Mount Sinai
New York, NY, USA
Eric R. Bates, MD
Professor of Internal Medicine
Division of Cardiovascular Diseases
Department of Internal Medicine
University of Michigan
Ann Arbor, MI, USA
Kevin P. Bliden, BS, MBA
Program Manager
Sinai Center for Thrombosis Research
Sinai Hospital of Baltimore
Baltimore, MD, USA
Laurent Bonello, MD, PhD
Medical Doctor (Cardiology)
Département de Cardiologie
Hôpital Nord
Chemin des Bourrely
Marseille, France
Nicoline J. Breet, MD, PhD
Cardiologist in Training
Department of Cardiology
St Antonius Hospital
Nieuwegein, The Netherlands
Andrzej Budaj, MD, PhD, FESC
Professor of Medicine
Director
Department of Cardiology
Postgraduate Medical School
Grochowski Hospital
Warsaw, Poland
Marco Cattaneo, MD
Professor of Internal Medicine
Dipartimento di Scienze della Salute
Unità di Medicina 3
Ospedale San Paolo
Università degli Studi di Milano
Milano, Italy
Matthew J. Chung, MD
Adjunct Assistant Professor of Medicine
Duke University Medical Center;
Hospitalist Physician
Durham Veterans Affairs Medical Center
Durham, NC, USA
Lidija Covic, PhD
Co-Director
Hemostasis and Thrombosis Laboratory
Molecular Oncology Research Institute
Division of Hematology/Oncology
Tufts Medical Center;
Assistant Professor of Medicine and Biochemistry
Tufts University School of Medicine
Boston, MA, USA
Flávio de Souza Brito, MD
Clinical Research Fellow
Division of Cardiology
Duke University Medical Center
Duke Clinical Research Institute
Durham, NC, USA
Germano di Sciascio, MD, FACC, FESC, FSCAI
Professor and Chairman of Cardiology
Department of Cardiovascular Sciences
Campus Bio-Medico University of Rome
Rome, Italy
Vijay A. Doraiswamy, MD, FACP
Fellow
Cardiovascular Medicine
University of Arizona
Tucson, AZ, USA
J. Emilio Exaire, MD
Assistant Professor of Medicine
The University of Oklahoma Health Sciences Center
Oklahoma City, OK, USA
Pierre Fontana, MD, PhD
Associate Professor
Co-director
Geneva Platelet Group
University of Geneva;
Division of Angiology and Haemostasis
Geneva University Hospitals and Faculty of Medicine
(Geneva Platelet Group)
Geneva, Switzerland
Francesco Franchi, MD
Postdoctoral Research Associate
University of Florida College of Medicine
Jacksonville, FL, USA
Michael A. Gaglia, Jr., MD, MSc
Assistant Professor of Medicine
Division of Cardiovascular Medicine
University of Southern California Keck School of Medicine
Los Angeles, CA, USA
Martin Gesheff, BS
Research Study Coordinator
Sinai Center for Thrombosis Research
Sinai Hospital of Baltimore
Baltimore, MD, USA
Paul A. Gurbel, MD, FACC, FAHA
Director, Sinai Center for Thrombosis Research
Associate Chief for Research
Department of Medicine
Sinai Hospital of Baltimore;
Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD;
Adjunct Professor of Medicine
Duke University School of Medicine
Durham, NC, USA
Christian Hamm, MD
Professor of Internal Medicine and Cardiology
Department of Internal Medicine and Cardiology
Kerckhoff Heart and Thorax Center
Bad Nauheim, Germany
Arnoud W.J. van’t Hof, MD, PhD
Interventional Cardiologist
Head
Department of Research
Isala Academy
Isala Klinieken
Zwolle, The Netherlands
Thomas Hohlfeld, MD
Professor of Pharmacology
Associate Director
Institute of Pharmacology and Clinical Pharmacology
UniversitätsKlinikum
Heinrich-Heine Universität Düsseldorf
Düsseldorf, Germany
Stefan James, MD, PhD
Director
Cardiac Catheterization Laboratory
Associate Professor of Cardiology
Uppsala Clinical Research Center;
Uppsala University Hospital
Uppsala, Sweden
Young-Hoon Jeong, MD, PhD
Associate Professor of Medicine
Division of Cardiology
Department of Internal Medicine
Gyeongsang National University Hospital
Jinju-si, South Korea
Jacek Kubica, MD, PhD
Professor of Medicine
Department of Cardiology and Internal Medicine
Ludwik Rydygier Collegium Medicum
Nicolaus Copernicus University
Bydgoszcz, Poland;
Systematic Investigation and Research on Interventions and Outcomes (SIRIO)-MEDICINE Research Network
Athan Kuliopulos, MD, PhD
Director
Hemostasis and Thrombosis Laboratory
Molecular Oncology Research Institute
Tufts Medical Center;
Professor of Medicine and Biochemistry
Tufts University School of Medicine
Boston, MA, USA
Marc Laine, MD
Medical Doctor (Cardiology)
Département de Cardiologie
Hôpital Nord
Chemin des Bourrely
Marseille, France
Ana Laynez, MD
Attending Physician
Division of Cardiology
Department of Internal Medicine
MedStar Washington Hospital Center
Washington, DC, USA
Seung-Whan Lee, MD
Associate Professor
Division of Cardiology
University of Ulsan College of Medicine
Asan Medical Center
Seoul, Republic of Korea
Eli I. Lev, MD
Associate Professor of Medicine and Cardiology
Department of Cardiology
Rabin Medical Center
Petah-Tikva;
Tel-Aviv University
Tel-Aviv, Israel
Joshua P. Loh, MBBS
Fellow
Interventional Cardiology
MedStar Washington Hospital Center
Washington, DC, USA
Fabio Mangiacapra, MD, PhD
Attending Cardiologist
Department of Cardiovascular Sciences
Campus Bio-Medico University of Rome
Rome, Italy
Ray V. Matthews, MD
Professor of Medicine
Director of Interventional Cardiology
Division of Cardiovascular Medicine
University of Southern California Keck School of Medicine
Los Angeles, CA, USA
Talha Meeran, MBBS
Resident
Sinai Center for Thrombosis Research
Sinai Hospital of Baltimore;
Johns Hopkins University School of Medicine
Baltimore, MD, USA
Roxana Mehran, MD, FACC
Professor of Medicine (Cardiology)
Director of Interventional Cardiovascular Research and Clinical Trials
The Zena and Michael A. Wiener Cardiovascular Institute
The Icahn School of Medicine at Mount Sinai;
Cardiovascular Research Foundation
New York, NY, USA
Rosetta Melfi, MD
Attending Cardiologist
Department of Cardiovascular Sciences
Campus Bio-Medico University of Rome
Rome, Italy
Sa’ar Minha, MD
Fellow
Interventional Cardiology
MedStar Washington Hospital Center
Washington, DC, USA
Ana Muñiz-Lozano, MD
Post-doctoral Research Associate
University of Florida College of Medicine
Jacksonville, FL, USA
Aung Myat, BSc(Hons), MB, BS, MRCP
SpR Cardiology & BHF Clinical Research Training Fellow
Cardiovascular Division
King’s College London BHF Centre of Research Excellence
The Rayne Institute
St Thomas’ Hospital
London, UK
Eliano Pio Navarese, MD, PhD
Interventional Cardiologist and Assistant Professor
Department of Cardiology and Internal Medicine
Ludwik Rydygier Collegium Medicum
Nicolaus Copernicus University
Bydgoszcz, Poland
President of Systematic Investigation and Research on Interventions and Outcomes (SIRIO)-MEDICINE Research Network
Annunziata Nusca, MD
Attending Cardiologist
Department of Cardiovascular Sciences
Campus Bio-Medico University of Rome
Rome, Italy
Martin Orban, MD
Cardiologist
Department of Cardiology
Medizinische Klinik und Poliklinik I
Klinikum der Universität München
Ludwig-Maximilians-Universität München
Munich, Germany
Anna Oskarsson, MSc
Research Fellow
Department of Medical Sciences, Cardiology
Uppsala Clinical Research Center
Uppsala,...
| Erscheint lt. Verlag | 24.3.2014 |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Schlagworte | Agents • Basic science • Book • Cardiologists • Class • clearheaded • clinically • combination • Complex • concise • discussion • Drugs • important • Interventional • Interventional cardiology • Invasive Kardiologie • Kardiovaskuläre Erkrankung • Kardiovaskuläre Erkrankung • leading • Medical Science • Medizin • New • Reader • resistance • solid • Team • therapies • Topics • Worlds |
| ISBN-10 | 1-118-49402-4 / 1118494024 |
| ISBN-13 | 978-1-118-49402-8 / 9781118494028 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich